Skip to main content
Fig. 8 | BMC Cancer

Fig. 8

From: Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

Fig. 8

Proliferation inhibition of SK-BR-3 cells in vitro. [3H]-thymidine proliferation assay demonstrating the effects of purified anti-P467 rabbit IgG antibodies on the Her-2/neu-overexpressing human breast cancer cell line SK-BR-3 and the human melanoma cell line 518.A2 as control cells (Her-2/neu negative). Data are expressed in percentage of inhibition, based on the mean (+ SEM) of the tested antibody isolates; cpm values of untreated wells were set to 100%. Significant difference is denoted by *. ns, not significant

Back to article page